Shire PLC’s Buy Rating Reaffirmed at Jefferies Group (SHPGY)
Other equities research analysts have also recently issued reports about the stock. Analysts at Susquehanna raised their price target on shares of Shire PLC from $220.00 to $260.00 in a research note on Friday. They now have a “positive” rating on the stock. Separately, analysts at JPMorgan Chase & Co. reiterated an “overweight” rating on shares of Shire PLC in a research note on Tuesday, June 17th. Finally, analysts at Barclays reiterated an “overweight” rating on shares of Shire PLC in a research note on Wednesday, May 21st. One equities research analyst has rated the stock with a hold rating and six have given a buy rating to the company. The stock presently has an average rating of “Buy” and a consensus target price of $260.00.
Shire plc (NASDAQ:SHPGY) is a specialty biopharmaceutical company that focuses on meeting the needs of the specialist physician.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.